Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- THE ROSEN LAW FIRM, P. A.DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud LawsuitWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DICK'S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the "Class Period"), of the important November...
- THE ROSEN LAW FIRM, P. A.ASTS Investors Have Opportunity to Lead AST SpaceMobile, Inc. Securities Fraud LawsuitWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the "Class Period"), of the important November 13, 2026 lead...
- NASDAQ: DUOL: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Duolingo, Inc.Did you buy DUOL Class A common stock between May 2, 2025 and February 26, 2026?
- Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Grabar Law Office is Investigating Claims on Your BehalfAardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corp. (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG)
- THE ROSEN LAW FIRM, P. A.CCB Investors Have Opportunity to Lead Coastal Financial Corporation Securities Fraud LawsuitWhy: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Coastal Financial Corporation (NASDAQ: CCB) between October 28, 2024 and July 29, 2026, inclusive (the "Class...
- THE ROSEN LAW FIRM, P. A.QFIN Investors Have Opportunity to Lead Qfin Holdings, Inc. Securities Fraud LawsuitWhy: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN) between March 18, 2026 and August 25, 2026, inclusive (the "Class Period"). A class...
- SMPL URGENT DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds The Simply Good Foods Company Investors of The Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Before October 13thIf you purchased or acquired Simply Good Foods common stock between October 24, 2024 and April 8, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
- THE ROSEN LAW FIRM, P. A.GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud LawsuitWhy: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Alphabet Inc. (NASDAQ: GOOGL, GOOG) between May 19, 2026 and July 16, 2026, inclusive (the "Class Period"). A class...
- THE ROSEN LAW FIRM, P. A.DNB Investors Have Opportunity to Lead Dun & Bradstreet Holdings, Inc. Securities Fraud Lawsuit FiledWhy: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) ("D&B") common stock in the open market from May 13, 2025 through August 26, 2025; (b) exchanged...
- Faruqi & Faruqi LLPAVEX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds AEVEX Investors of Securities Class Action Lawsuit Deadline on October 20, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AEVEX To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in AEVEX between April 17, 2026 and June 4, 2026 or otherwise acquired Aevex Class A common stock pursuant or traceable to the registration statement and prospectus (the "IPO Offering Documents") issued in connection with Aevex's April 17, 2026 initial public offering ("IPO") and would like...
- 业绩连增三年，东莞证券IPO为何仍卡在“已受理”？（来源：每财网） 递交IPO申请十一年，招股书更新到第八版，审核状态却始终停在“已受理”三个字上。 文/每日财报 南黎 递交IPO申请十一年，招股书更新到第八版，审核状态却始终停在“已受理”三个字上。更戏剧性的是，一个多月内，两位曾掌舵或分管核心业务的前高管先后主动投案。一边是连续三年业绩增长、国资火速加码，一边是IPO纹丝不动，这家老牌券商的上市之路，到底卡在了哪里？ 一场超过十年的上市长跑 东莞证券的故事，要从1988年说起。这家由中国人民银行东莞分行出资设立的金融机构，是全国首批承销保荐机构之一。2015年6月，它向证监会递交了IPO申请材料，成为广东地区最早一批谋求上市的中小券商。 然而这条上市之路走得异常坎坷。2017年5月，因第一大股东 锦龙股份 实控人杨志茂涉嫌单位行贿被立案侦查，东莞证券主动申请中止IPO审查，上市进程戛然而止。沉寂四年后，2021年审核恢复，2022年2月首发顺利过会，距离上市仅一步之遥。但过会
- LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP CongressLB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The posters highlight new preclinical data describing LB-102’s differentiated mechanism of action, the pivotal program of LB-102 in schizophrenia (NOVA-2 and NOVA-3), the ongoing late-stage development of LB-102 in bipolar depression (ILLUMINATE-1), and a previously reported analysis of LB-102’s impact on cognitive performance from the Phase 2 NOVA-1 trial in schizophrenia.